Dabrafenib Mesylate

Thông số

1195768-06-9Số CAS

689-167-4Số EC

N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acidTên IUPAC

C24H24F3N5O5S3Công thức hóa học

615.7 g/molKhối lượng phân tử

Dabrafenib mesylate; 1195768-06-9; Taflinar; UNII-B6DC89I63E; GSK 2118436B; GSK-2118436B; Dabrafenib methanesulfonate; GSK2118436B; B6DC89I63E; dabrafenib monomesylate; GSK-2118436B MESYLATE; GSK2118436 Methane sulfonate salt; GSK2118436B, methane sulfonate salt; GSK-2118436 METHANESULFONATE SALT; Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1); GSK-2118436B METHANESULFONATE SALT; CHEBI:75048; DTXSID70152500; BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)-2-FLUOROPHENYL)-2,6-DIFLUORO-, METHANESULFONATE (1:1); N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate; N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate; RefChem:58041; DTXCID3074991; N-(3-(5-(2-AMINOPYRIMIDIN-4-YL)-2-(1,1-DIMETHYLETHYL)THIAZOL-4-YL)-2-FLUOROPHENYL)-2,6-DIFLUOROBENZENESULFONAMIDE MONOMETHANESULFONATE; Dabrafenib (Mesylate); dabrafenib mesilate; N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate; Dabrafenib mesylate [USAN]; GSK-2118436 mesylate; MFCD20922872; METHANE SULFONATE SALT; GSK 2118436; GSK2118436 Mesylate;GSK 2118436B; Dabrafenib mesilate (JAN); Dabrafenib mesylate (USAN); N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid; DABRAFENIB MESILATE [JAN]; Tafinlar (TN); Dabrafenib Mesylate?; orb1220071; orb1298903; SCHEMBL1127269; CHEMBL2105729; DABRAFENIB MESYLATE [MI]; SCHEMBL29352214; C24H24F3N5O5S3; YKGMKSIHIVVYKY-UHFFFAOYSA-N; GLXC-90125; HMS5084M19; EX-A1559; ARD193678; DABRAFENIB MESILATE [WHO-DD]; HY-14660A; s5069; AKOS025396661; CCG-270246; CS-1641; EBC-101133; DABRAFENIB MESYLATE [ORANGE BOOK]; AC-31302; AS-17010; DA-72536; FD158016; SY260049; T8474; D10104; F857765; SR-01000941590; SR-01000941590-1; Q27145089; GSK2118436 Ms salt, Dabrafenib Ms salt, GSK2118436A Ms salt; BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)- 2-FLUOROPHENYL)-2,6-DIFLUORO-, METHANESULFONATE (1:1); Methanesulfonic acid--N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzene-1-sulfonamide (1/1); N-(3-(5-(2-AMINOPYRIMIDIN-4-YL)-2-(1,1-DIMETHYLETHYL)THIAZOL-4-YL)-2-FLUOROPHENYL)-2,6- DIFLUOROBENZENESULFONAMIDE MONOMETHANESULFONATE; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide Methanesulfonate; N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-thiazol-4-yl]-2-fluoro-phenyl]-2,6-difluoro-benzenesulfonamide methanesulfonic acid; N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-thiazol-4-yl]-2-fluoro-phenyl]-2,6-difluoro-benzenesulfonamide;methanesulfonic acid; N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate; Dabrafenib Mesylate MicronizedTên gọi khác